Pumas

UMB Grants Pumas-AI Exclusive License for Lyv, a Cutting-Edge Clinical Decision Support System

May 7, 2020

Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

Pumas-AI Launches Pumas Software to Advance Drug Development, Patient Care

July 19, 2019

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.